We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on...
Keep Reading →
October 27 - Hedge Funds, News - Comments
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However...
Keep Reading →
September 7 - Hedge Funds, News - Comments
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Keep Reading →
July 13 - Hedge Funds, News - Comments
In this article we will take a look at whether hedge funds think Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) is a good investment right now. We check...
Keep Reading →
June 3 - Hedge Funds, News - Comments
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Keep Reading →
April 7 - Hedge Funds, News - Comments
Is Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive...
Keep Reading →
December 10 - Hedge Funds, News - Comments
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through October 17th. Among them, Facebook and...
Keep Reading →
October 27 - Hedge Funds, News - Comments
How do we determine whether Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) makes for a good investment at the moment? We analyze the sentiment of a select...
Keep Reading →
May 3 - Hedge Funds, News - Comments
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred...
Keep Reading →
December 17 - Hedge Funds, News - Comments
Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories. This...
Keep Reading →
February 22 - News, Stock Analysis - Comments
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited...
Keep Reading →
December 7 - Hedge Funds, News - Comments
It’s a little-known fact that stock performance is not evenly distributed (i.e. you don’t have a 50/50 chance of picking a market-beating...
Keep Reading →
November 30 - Hedge Funds, News - Comments
Jacob Gottlieb’s Visium Asset Management, Richard Gerson and Navroz D. Udwadia’s Falcon Edge Capital, and Richard Barrera’s Roystone Capital Management...
Keep Reading →
April 29 - Hedge Funds, News - Comments
Steven Cohen has continued into the spring cleaning of his equity portfolio, reducing stakes in several stocks. This is the third wave of filings with...
Keep Reading →
April 7 - Hedge Funds, News - Comments
Steven Cohen’s SAC Capital Advisors has reported adding Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) to its equity portfolio. SAC Capital Advisors currently...
Keep Reading →
March 13 - Hedge Funds, News - Comments
Is Akorn, Inc. (NASDAQ:AKRX) a buy? To many of your peers, hedge funds are viewed as useless, old investment tools of an era lost to time. Although there...
Keep Reading →
September 11 - News - Comments
Should Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) investors track the following data? Now, according to many market players, hedge funds are assumed...
Keep Reading →
September 4 - News - Comments
Should Hi-Tech Pharmacal Co. (NASDAQ:HITK) investors track the following data? To the average investor, there are tons of gauges investors can use to...
Keep Reading →
September 3 - News - Comments
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age. Although there are over 8,000...
Keep Reading →
September 3 - News - Comments
Is Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) going to burn you? In the 21st century investor’s toolkit, there are dozens of methods shareholders can...
Keep Reading →
August 27 - News - Comments
Is Mylan Inc. (NASDAQ:MYL) a buy? To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time. Although...
Keep Reading →
August 25 - News - Comments
The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals...
Keep Reading →
August 2 - News - Comments
It isn’t very often that an agency sometimes accused of over-regulating an industry can be ridiculed for not regulating enough, but that’s...
Keep Reading →
August 2 - News - Comments
The United States Court of Appeals is making this one miserable summer for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). In June, it was determined...
Keep Reading →
July 29 - News - Comments
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) shareholders have witnessed an increase in hedge fund interest of late. At the moment, there are dozens of methods...
Keep Reading →
July 5 - News - Comments
Love it or hate it, the Patient Protection and Affordable Care Act — commonly referred to as Obamacare — changes the health care landscape...
Keep Reading →
July 5 - News - Comments
It’s understandably very tempting for people with inside information to trade biotech stocks. With the potential for overnight doubles and triples...
Keep Reading →
June 17 - News - Comments
Generic-drug makers are always on the hunt for the next branded drug to take down. But they can’t just go about launching copycats of every drug...
Keep Reading →
June 13 - News - Comments
Sagent Pharmaceuticals Inc (NASDAQ:SGNT) investors should pay attention to a decrease in activity from the world’s largest hedge funds recently....
Keep Reading →
June 10 - News - Comments
Hi-Tech Pharmacal Co. (NASDAQ:HITK) investors should be aware of a decrease in support from the world’s most elite money managers lately. In the...
Keep Reading →
June 10 - News - Comments
Is Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) the right pick for your portfolio? Money managers are buying. The number of bullish hedge fund bets improved...
Keep Reading →
June 6 - News - Comments
Everyone loves owning dividend stocks. They may not drive your investment strategy, but you sure don’t mind getting paid just to own a company....
Keep Reading →
May 30 - News - Comments
Earlier this month, Baxter International Inc. (NYSE:BAX) reported that the clinical trials for the treatment of Alzheimer’s disease (Gammagard) had...
Keep Reading →
May 29 - News - Comments
Take one look at the returns from biotech darlings Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc. (NASDAQ...
Keep Reading →
April 30 - News - Comments
Hi-Tech Pharmacal Co. (NASDAQ:HITK) was in 11 hedge funds’ portfolio at the end of December. HITK investors should be aware of an increase in hedge...
Keep Reading →
April 10 - News - Comments
Is Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) an exceptional investment now? Prominent investors are buying. The number of long hedge fund positions...
Keep Reading →
April 8 - News - Comments
Despite its name, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has been losing steam since the end of 2011 with revenue falling 97% in the last nine months...
Keep Reading →
February 5 - News - Comments